Effect of the neuropathic pain receptor P2X3 on bladder function induced by intraperitoneal injection of cyclophosphamide (CYP) in interstitial cystitis rats

被引:4
作者
Pang, Lei [1 ,2 ]
Shao, Jinkai [2 ]
Wen, Xiaodong [2 ]
Liu, Dong [2 ]
Zhang, Zhijia [2 ]
Shuang, Weibing [3 ]
机构
[1] Shanxi Med Univ, Dept Grad, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Dept Urol, Affiliated Hosp 5, Taiyuan, Peoples R China
[3] Shanxi Med Univ, Dept Urol, Affiliated Hosp 1, 85 Jiefang South Rd, Taiyuan 030001, Peoples R China
关键词
P2X3; interstitial cystitis (IC); overactive bladder; neuropathic pain; URINARY-BLADDER; ANIMAL-MODEL; SENSITIZES; CELLS;
D O I
10.21037/tau-22-23
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background: The role of purinergic receptor P2X3 in pathological bladder dysfunction and chronic pelvic pain remains unclear. We aim to investigate the effect of P2X3 on bladder function in interstitial cystitis (IC) through the IC rat model induced by cyclophosphamide (CYP). Methods: A total of 120 female Sprague-Dawley (SD) rats were randomly divided into 6 groups: control, CYP-4h, CYP-48h, CYP-10d, CYP-30d, and CYP-45d groups. The control group was injected with normal saline. The rats in the CYP-4h and CYP-48h groups were given a single high dose. The rats in the CYP-10d, CYP-30d, and CYP-45d groups were given a low dose of CYP repeatedly every three days. Bladder voiding function was measured using urodynamic techniques to observe the effect of the P2X3 receptor on bladder function in CYP-induced IC. Results: The rats in the CYP-4h group showed significant overactivity of the bladder compared with the control group, the bladder voiding interval was shortened (P<0.01), and the maximal voiding pressure was increased (P<0.01). At the same time, the degree of overactive bladder in the CYP-48h, CYP-10d, CYP-30d, and CYP-45d groups became increasingly serious, the interval of bladder micturition was shortened stepwise (P<0.01), and the maximal micturition pressure was increased stepwise (P<0.01). Compared with the control group, the CYP-48h group mainly showed a shorter bladder voiding interval (P<0.01), lower voiding volume, and higher activation of mast cells and inflammatory factors in the bladder. In the CYP-10d group, bladder mast cell activation and inflammatory factors increased significantly. Intrathecal injection (IT) of A-317491 significantly prolonged the bladder voiding intervals in CYP-4h, CYP-48h, CYP-1(ki, CYP-30d, and CYP45d rats (P<0.01), and the maximal voiding pressure of the CYP-4h, CYP-48h, CYP-10d, CYP-30d, and CYP-45d groups was significantly decreased (P<0.05), while the maximal voiding pressure of the CYP-10d group was not significantly affected. Conclusions: P2X3 receptors in dorsal root ganglia (DGR) play an important role in bladder function induced by intraperitoneal injection of CYP in rats. IT of P2X3 inhibitors can significantly improve the grade of bladder voiding dysfunction and chronic pelvic pain.
引用
收藏
页码:304 / 312
页数:9
相关论文
共 50 条
  • [41] PK2/PKR1 Signaling Regulates Bladder Function and Sensation in Rats with Cyclophosphamide-Induced Cystitis
    Chen, Biao
    Zhang, Huiping
    Liu, Lili
    Wang, Jiaojiao
    Ye, Zhangqun
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [42] Neohesperidin Alleviates the Neuropathic Pain Behavior of Rats by Downregulating the P2X4 Receptor
    Yueying Wang
    Chenxi Li
    Jingming Xing
    Yan Zhu
    Minghao Sun
    Sui Yin
    Jianming Liu
    Lifang Zou
    Shangdong Liang
    Shuangmei Liu
    Neurochemical Research, 2023, 48 : 781 - 790
  • [43] Neohesperidin Alleviates the Neuropathic Pain Behavior of Rats by Downregulating the P2X4 Receptor
    Wang, Yueying
    Li, Chenxi
    Xing, Jingming
    Zhu, Yan
    Sun, Minghao
    Yin, Sui
    Liu, Jianming
    Zou, Lifang
    Liang, Shangdong
    Liu, Shuangmei
    NEUROCHEMICAL RESEARCH, 2023, 48 (03) : 781 - 790
  • [44] Effect of emodin on neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons
    Gao, Yun
    Liu, Han
    Deng, Libin
    Zhu, Gaochun
    Xu, Changshui
    Li, Guilin
    Liu, Shuangmei
    Xie, Jinyan
    Liu, Jun
    Kong, Fanjun
    Wu, Raoping
    Li, Guodong
    Liang, Shangdong
    BRAIN RESEARCH BULLETIN, 2011, 84 (06) : 406 - 413
  • [45] Modulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2/3 receptors
    Munoz, Alvaro
    Somogyi, George T.
    Boone, Timothy B.
    Ford, Anthony P.
    Smith, Christopher P.
    BJU INTERNATIONAL, 2012, 110 (8B) : E409 - E414
  • [46] Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice
    Hansen, Rikke Rie
    Nasser, Arafat
    Falk, Sarah
    Baldvinsson, Signe B.
    Ohlsson, Pernille H.
    Bahl, Justyna M. C.
    Jarvis, Michael F.
    Ding, Ming
    Heegaard, Anne-Marie
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 688 (1-3) : 27 - 34
  • [47] Enhanced binding capability of nuclear factor-κB with demethylated P2X3 receptor gene contributes to cancer pain in rats
    Zhou, You-Lang
    Jiang, Guo-Qin
    Wei, Jinrong
    Zhang, Hong-Hong
    Chen, Wei
    Zhu, Hongyan
    Hu, Shufen
    Jiang, Xinghong
    Xu, Guang-Yin
    PAIN, 2015, 156 (10) : 1892 - 1905
  • [48] Rho/ROCK acts downstream of lysophosphatidic acid receptor 1 in modulating P2X3 receptor-mediated bone cancer pain in rats
    Wu, Jing-xiang
    Yuan, Xiao-min
    Wang, Qiong
    Wei, Wang
    Xu, Mei-ying
    MOLECULAR PAIN, 2016, 12
  • [49] Gardenoside suppresses the pain in rats model of chronic constriction injury by regulating the P2X3 and P2X7 receptors
    Yu, Mingdong
    Su, Baohui
    Zhang, Xiaoxia
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2018, 38 (03) : 198 - 203
  • [50] Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats
    Teixeira, Juliana Maia
    Oliveira, Maria Claudia G.
    Nociti, F. H., Jr.
    Clemente-Napimoga, J. T.
    Pelegrini-da-Silva, Adriana
    Parada, Carlos Amilcar
    Tambeli, Claudia Herrera
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 645 (1-3) : 79 - 85